2019
DOI: 10.1007/s10072-019-03785-8
|View full text |Cite
|
Sign up to set email alerts
|

Excessive daytime sleepiness and its impact on quality of life in de novo Parkinson’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
20
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(22 citation statements)
references
References 33 publications
1
20
1
Order By: Relevance
“…Our study indicated that EDS, evaluated by the ESS, was different among the three groups. In addition, consistent with previous studies that investigated the impacts of EDS on QoL (Kuhlman et al, 2019;Xiang et al, 2019;Yoo et al, 2019), we found that EDS was an important contributor to QoL in all PD patients. It was reported that EDS was independently correlated to cognitive impairment in PD (Marinus et al, 2018).…”
Section: Discussionsupporting
confidence: 92%
“…Our study indicated that EDS, evaluated by the ESS, was different among the three groups. In addition, consistent with previous studies that investigated the impacts of EDS on QoL (Kuhlman et al, 2019;Xiang et al, 2019;Yoo et al, 2019), we found that EDS was an important contributor to QoL in all PD patients. It was reported that EDS was independently correlated to cognitive impairment in PD (Marinus et al, 2018).…”
Section: Discussionsupporting
confidence: 92%
“…Excessive daytime sleepiness (EDS), which refers to the inability to stay awake and alert during the day with sleep occurring at inappropriate times (Zhu et al, 2016) is a ubiquitous non-motor symptom in Parkinson's disease (PD). Convergent evidence has suggested that EDS is associated with falls, other non-motor symptoms (e.g., depression), and poorer quality of life in PD (Spindler et al, 2013;Chen et al, 2014;Yoo et al, 2019). Understanding the pathogenesis of EDS in PD is important to guide future treatment development.…”
Section: Introductionmentioning
confidence: 99%
“… 53 It is well recognized that EDS, measured by ESS, negatively impacts QoL in PD. 47 , 54 In this study, we found that ESS was an independent determinant of QoL in both PD‐MMP and PD‐IM patients, while it had no significant impact on QoL in PD‐DM patients. Except for male sex, the use of dopamine agonists is the greatest independent risk factor for EDS 37 , and it seems to increase EDS in a dose‐dependent manner.…”
Section: Discussionmentioning
confidence: 57%